Edward Gane

Also affiliated with Auckland City Hospital, Auckland University of Technology

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Safety and Efficacy of Inotersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (NEURO-TTR) (N2.001)”.

Safety and Efficacy of Inotersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (NEURO-TTR) (N2.001)

Neurology(2018)10.1212/wnl.90.15_supplement.n2.001

N/A

0.125DataRank · unranked

1 citations

Annabel K. Wang, Teresa Coelho, Marcia Waddington Cruz, Michael J. Polydefkis, Peter J. Dyck +26 more

Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease

JCI Insight(2020)10.1172/jci.insight.135348

N/A

0DataRank · unranked

59 citations

Keith Blomenkamp, Ryan M. Peterson, Владимир Субботин, Christian Schwabe, James Hamilton +12 more